The Council for Federal Cannabis Regulation (CFCR) announced that their next monthly webinar, scheduled for Thursday, March 30 1:00 until 2:00 p.m. ET, will focus on the rise of Intoxicating Hemp Derived Cannabinoids, also commonly referred to as delta-8 THC, delta-10 THC, and hexahydrocannabinol (HHC).
Legal in most states since it is not scheduled under the Controlled Substance Act, these products extracted from hemp have raised the ire of both lawmakers and legal dispensaries and retailers, who find themselves at odds when dealing with a product that is not at all regulated.
“Our upcoming webinar will focus on the vacuum now faced by state legislators and regulators with regards to these Intoxicating Hemp Derived Cannabinoids,” said CANNRA Executive Director Dr. Gillian Schauer. “Our discussion will focus on state regulators’ perspectives, the issues surrounding delta-8 and delta-10, and possible approaches to such regulation.” The webinar will also look closely at a Colorado Task Force Case Study, which focuses on the rise of delta-8, mapping the product’s emergence while also focusing on the next steps, lessons learned, and possible approaches to legislation and regulation.
Co-hosted by CFCR Executive Director Kris Michelle, along with Council Advisory Board Member Jack Jacobson, a cannabis, energy, and education practices advisor for Thompson Coburn LLC. The webinar will feature four prestigious panelists -- Michael Bronstein, President and CoFounder of the American Trade Association for Cannabis & Hemp (ATACH); Dr. Gillian Schauer, Executive Director of the Cannabis Regulators Association; Christian Sederberg, founding Partner of Vincente Sederberg; and Kay Doyle, Founder of Oui Coaching & Consulting.
CFCR’s monthly webinars take place on the last Thursday of every month (depending on holidays), with each one spotlighting a wide range of regulators, legislators, and industry professionals with a focus on preparing to regulate today’s legal cannabis molecules and products. Each webinar will consist of a 40-minute interactive conversation followed by approximately 20 minutes of moderated audience Q&A for a total run-time of approximately one hour.
For more information:
Council for Federal Cannabis Regulation